BRITTANY SAUERBORN: Open Payments
NPI 1538434923 · BEAUFORT, SC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$8,562 in 61 payments from 9 companies in 2025. Trend: 2023 $11,037 · 2024 $7,596 · 2025 $8,562
Consulting: $4,500Speaker / faculty: $2,250Food & beverage: $1,100Travel & lodging: $712
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 12 | $5,377 |
| ABBVIE INC. | 6 | $2,361 |
| Teva Pharmaceuticals USA, Inc. | 14 | $277 |
| E.R. Squibb & Sons, L.L.C. | 13 | $226 |
| Alkermes, Inc. | 6 | $122 |
| Otsuka America Pharmaceutical, Inc. | 4 | $82 |
| Neurocrine BioSciences, Inc. | 3 | $64 |
| Janssen Pharmaceuticals, Inc | 2 | $39 |
| Supernus Pharmaceuticals, Inc. | 1 | $14 |
Products named: CAPLYTA, VRAYLAR, COBENFY, AUSTEDO XR, ARISTADA, INGREZZA, REXULTI, UZEDY.
Industry payments across SC — which companies pay providers there.
